94 related articles for article (PubMed ID: 23702823)
1. Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy?
Molinari C; Casadio V; Foca F; Zingaretti C; Giannini M; Avanzolini A; Lucci E; Saragoni L; Passardi A; Amadori D; Calistri D; Zoli W
J Cell Physiol; 2013 Dec; 228(12):2343-9. PubMed ID: 23702823
[TBL] [Abstract][Full Text] [Related]
2. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation.
Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
J Pathol; 2006 Jan; 208(1):100-7. PubMed ID: 16278815
[TBL] [Abstract][Full Text] [Related]
3. Prediction of response to preoperative chemoradiotherapy in rectal cancer by using reverse transcriptase polymerase chain reaction analysis of four genes.
Watanabe T; Kobunai T; Akiyoshi T; Matsuda K; Ishihara S; Nozawa K
Dis Colon Rectum; 2014 Jan; 57(1):23-31. PubMed ID: 24316942
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.
Cosialls AM; Santidrián AF; Coll-Mulet L; Iglesias-Serret D; González-Gironès DM; Pérez-Perarnau A; Rubio-Patiño C; González-Barca E; Alonso E; Pons G; Gil J
Epigenomics; 2012 Oct; 4(5):491-501. PubMed ID: 23130831
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.
Lopes-Ramos C; Koyama FC; Habr-Gama A; Salim AC; Bettoni F; Asprino PF; França GS; Gama-Rodrigues J; Parmigiani RB; Perez RO; Galante PA; Camargo AA
Cancer Genet; 2015 Jun; 208(6):319-26. PubMed ID: 25963525
[TBL] [Abstract][Full Text] [Related]
7. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D
Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease.
Pesek M; Kopeckova M; Benesova L; Meszarosova A; Mukensnabl P; Bruha F; Minarik M
Anticancer Res; 2011 Dec; 31(12):4647-52. PubMed ID: 22199344
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and sensitivity to antimetabolites in cancer cell lines.
Sasaki S; Kobunai T; Kitayama J; Nagawa H
Oncol Rep; 2008 Feb; 19(2):407-12. PubMed ID: 18202788
[TBL] [Abstract][Full Text] [Related]
12. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.
Grimminger PP; Danenberg P; Dellas K; Arnold D; Rödel C; Machiels JP; Haustermans K; Debucquoy A; Velenik V; Sempoux C; Bracko M; Hölscher AH; Semrau R; Yang D; Danenberg K; Lenz HJ; Vallböhmer D
Clin Cancer Res; 2011 May; 17(10):3469-77. PubMed ID: 21558395
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
15. Methylation analysis of tumor suppressor genes in endometroid carcinoma of endometrium using MS-MLPA.
Dvorakova E; Chmelarova M; Laco J; Palicka V; Spacek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):298-303. PubMed ID: 23736679
[TBL] [Abstract][Full Text] [Related]
16. Methylation profiling of rectal cancer identifies novel markers of early-stage disease.
Leong KJ; Wei W; Tannahill LA; Caldwell GM; Jones CE; Morton DG; Matthews GM; Bach SP
Br J Surg; 2011 May; 98(5):724-34. PubMed ID: 21360524
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma.
Brettingham-Moore KH; Duong CP; Greenawalt DM; Heriot AG; Ellul J; Dow CA; Murray WK; Hicks RJ; Tjandra J; Chao M; Bui A; Joon DL; Thomas RJ; Phillips WA
Clin Cancer Res; 2011 May; 17(9):3039-47. PubMed ID: 21224373
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
[TBL] [Abstract][Full Text] [Related]
19. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L
Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
